Cargando…

Blood borne transit of CJD from brain to gut at early stages of infection

BACKGROUND: In Creutzfeldt-Jakob disease (CJD) and other related transmissible spongiform encephalopathies it is critical to understand the various pathways by which the infectious agent spreads to different organs. METHODS: We injected a CJD agent into mice, either intracerebrally (ic) or intraperi...

Descripción completa

Detalles Bibliográficos
Autores principales: Radebold, Klaus, Chernyak, Mark, Martin, Daniel, Manuelidis, Laura
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2001
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59894/
https://www.ncbi.nlm.nih.gov/pubmed/11716790
http://dx.doi.org/10.1186/1471-2334-1-20
_version_ 1782120109717848064
author Radebold, Klaus
Chernyak, Mark
Martin, Daniel
Manuelidis, Laura
author_facet Radebold, Klaus
Chernyak, Mark
Martin, Daniel
Manuelidis, Laura
author_sort Radebold, Klaus
collection PubMed
description BACKGROUND: In Creutzfeldt-Jakob disease (CJD) and other related transmissible spongiform encephalopathies it is critical to understand the various pathways by which the infectious agent spreads to different organs. METHODS: We injected a CJD agent into mice, either intracerebrally (ic) or intraperitoneally (ip) and monitored the progressive appearance of abnormal PrP in peripheral tissues over time. RESULTS: Abnormal PrP was detected in lymphoreticular tissues of the gastrointestinal tract as early as 28 to 32 days after infection by both routes. This change persisted until the terminal stages of disease. In contrast, abnormal PrP was not detected in brain or spinal cord until 80 to 120 days after ic inoculation, or until 170 days after ip inoculation. CONCLUSIONS: Brain lacks significant lymphatic drainage, and has little infectivity before 40 days, even after ic inoculation. Thus the infectious inoculum must spread to the gut by a vascular route, a direction opposite to that generally assumed. This interpretation is consistent with previous studies demonstrating white blood cell infectivity as well as perivascular PrP accumulations in CJD. Notably, enteric infection at early as well as later stages of disease, and regardless of the route of agent entry, implicates potential environmental spread by fecal matter.
format Text
id pubmed-59894
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-598942001-11-21 Blood borne transit of CJD from brain to gut at early stages of infection Radebold, Klaus Chernyak, Mark Martin, Daniel Manuelidis, Laura BMC Infect Dis Research Article BACKGROUND: In Creutzfeldt-Jakob disease (CJD) and other related transmissible spongiform encephalopathies it is critical to understand the various pathways by which the infectious agent spreads to different organs. METHODS: We injected a CJD agent into mice, either intracerebrally (ic) or intraperitoneally (ip) and monitored the progressive appearance of abnormal PrP in peripheral tissues over time. RESULTS: Abnormal PrP was detected in lymphoreticular tissues of the gastrointestinal tract as early as 28 to 32 days after infection by both routes. This change persisted until the terminal stages of disease. In contrast, abnormal PrP was not detected in brain or spinal cord until 80 to 120 days after ic inoculation, or until 170 days after ip inoculation. CONCLUSIONS: Brain lacks significant lymphatic drainage, and has little infectivity before 40 days, even after ic inoculation. Thus the infectious inoculum must spread to the gut by a vascular route, a direction opposite to that generally assumed. This interpretation is consistent with previous studies demonstrating white blood cell infectivity as well as perivascular PrP accumulations in CJD. Notably, enteric infection at early as well as later stages of disease, and regardless of the route of agent entry, implicates potential environmental spread by fecal matter. BioMed Central 2001-10-25 /pmc/articles/PMC59894/ /pubmed/11716790 http://dx.doi.org/10.1186/1471-2334-1-20 Text en Copyright © 2001 Radebold et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
spellingShingle Research Article
Radebold, Klaus
Chernyak, Mark
Martin, Daniel
Manuelidis, Laura
Blood borne transit of CJD from brain to gut at early stages of infection
title Blood borne transit of CJD from brain to gut at early stages of infection
title_full Blood borne transit of CJD from brain to gut at early stages of infection
title_fullStr Blood borne transit of CJD from brain to gut at early stages of infection
title_full_unstemmed Blood borne transit of CJD from brain to gut at early stages of infection
title_short Blood borne transit of CJD from brain to gut at early stages of infection
title_sort blood borne transit of cjd from brain to gut at early stages of infection
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59894/
https://www.ncbi.nlm.nih.gov/pubmed/11716790
http://dx.doi.org/10.1186/1471-2334-1-20
work_keys_str_mv AT radeboldklaus bloodbornetransitofcjdfrombraintogutatearlystagesofinfection
AT chernyakmark bloodbornetransitofcjdfrombraintogutatearlystagesofinfection
AT martindaniel bloodbornetransitofcjdfrombraintogutatearlystagesofinfection
AT manuelidislaura bloodbornetransitofcjdfrombraintogutatearlystagesofinfection